换一批
换一批摘要篇首： Recent studies suggest that treatment with angiotensin Ⅱ type 1 (AT1) receptor blockers and lipid lowering agents, namely the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, or statins may have beneficial effects on renal function independent of lowering actions on blood pressure and cholesterol.
更多相关知识
关键词
angiotensin Ⅱ type 1 receptor blockersstatinsNF-kappa Bmonocyte chemoattractant protein-1diabetes mellitus
分类号
R58
栏目名称
发布时间
2005-07-07
- 浏览130
- 被引7
- 下载0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
